BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29334822)

  • 21. Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.
    Callens C; Coulon S; Naudin J; Radford-Weiss I; Boissel N; Raffoux E; Wang PH; Agarwal S; Tamouza H; Paubelle E; Asnafi V; Ribeil JA; Dessen P; Canioni D; Chandesris O; Rubio MT; Beaumont C; Benhamou M; Dombret H; Macintyre E; Monteiro RC; Moura IC; Hermine O
    J Exp Med; 2010 Apr; 207(4):731-50. PubMed ID: 20368581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel ring-substituted diindolylmethane,1,1-bis[3'-(5-methoxyindolyl)]-1-(p-t-butylphenyl) methane, inhibits extracellular signal-regulated kinase activation and induces apoptosis in acute myelogenous leukemia.
    Contractor R; Samudio IJ; Estrov Z; Harris D; McCubrey JA; Safe SH; Andreeff M; Konopleva M
    Cancer Res; 2005 Apr; 65(7):2890-8. PubMed ID: 15805291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
    Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S1PR1 mediates anti‑apoptotic/pro‑proliferative processes in human acute myeloid leukemia cells.
    Xu XQ; Huang CM; Zhang YF; Chen L; Cheng H; Wang JM
    Mol Med Rep; 2016 Oct; 14(4):3369-75. PubMed ID: 27572094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity.
    Heo SK; Noh EK; Yoon DJ; Jo JC; Park JH; Kim H
    PLoS One; 2014; 9(2):e98859. PubMed ID: 24918603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells.
    Zhou X; Fang Y; Jing H; Zhong L; Luo P; Song H; Yang B; He Q
    Mol Carcinog; 2013 Jan; 52(1):18-28. PubMed ID: 22006557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting ferroptosis contributes to ATPR-induced AML differentiation via ROS-autophagy-lysosomal pathway.
    Du Y; Bao J; Zhang MJ; Li LL; Xu XL; Chen H; Feng YB; Peng XQ; Chen FH
    Gene; 2020 Sep; 755():144889. PubMed ID: 32534056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antineoplastic effects of CPPTL via the ROS/JNK pathway in acute myeloid leukemia.
    Gao HE; Sun Y; Ding YH; Long J; Liu XL; Yang M; Ji Q; Li YH; Chen Y; Zhang Q; Gao YD
    Oncotarget; 2017 Jun; 8(24):38990-39000. PubMed ID: 28473664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia.
    Honma Y
    Leuk Lymphoma; 2002 Jun; 43(6):1169-78. PubMed ID: 12152984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsatilla saponin A induces differentiation in acute myeloid leukemia in vitro.
    Wang T; Gong F; Zhang R; Cen J; Dai L; Zhu M; Qi X
    Hematology; 2016 Apr; 21(3):182-6. PubMed ID: 26868262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bis(acetylacetonato)-oxidovanadium(IV) and sodium metavanadate inhibit cell proliferation via ROS-induced sustained MAPK/ERK activation but with elevated AKT activity in human pancreatic cancer AsPC-1 cells.
    Wu JX; Hong YH; Yang XG
    J Biol Inorg Chem; 2016 Dec; 21(8):919-929. PubMed ID: 27614430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
    Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
    Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells.
    Xie N; Zhong L; Liu L; Fang Y; Qi X; Cao J; Yang B; He Q; Ying M
    Biochem Pharmacol; 2014 May; 89(1):74-85. PubMed ID: 24607273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sorafenib Inhibition of Mcl-1 Accelerates ATRA-Induced Apoptosis in Differentiation-Responsive AML Cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Clin Cancer Res; 2016 Mar; 22(5):1211-21. PubMed ID: 26459180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effector mechanisms of sunitinib-induced G1 cell cycle arrest, differentiation, and apoptosis in human acute myeloid leukaemia HL60 and KG-1 cells.
    Teng CL; Yu CT; Hwang WL; Tsai JR; Liu HC; Hwang GY; Hsu SL
    Ann Hematol; 2013 Mar; 92(3):301-13. PubMed ID: 23180436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia.
    Eriksson A; Kalushkova A; Jarvius M; Hilhorst R; Rickardson L; Kultima HG; de Wijn R; Hovestad L; Fryknäs M; Öberg F; Larsson R; Parrow V; Höglund M
    Biochem Pharmacol; 2014 Jan; 87(2):284-91. PubMed ID: 24200998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of biological activities of vibsanin A analogs.
    Matsuki W; Miyazaki S; Yoshida K; Ogura A; Sasazawa Y; Takao KI; Simizu S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4536-4539. PubMed ID: 28888819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ursolic acid induces HL60 monocytic differentiation and upregulates C/EBPβ expression by ERK pathway activation.
    Zhang T; He YM; Wang JS; Shen J; Xing YY; Xi T
    Anticancer Drugs; 2011 Feb; 22(2):158-65. PubMed ID: 20948428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel analogs of 1,25-dihydroxyvitamin D
    Nachliely M; Sharony E; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vibsane-Type Diterpenoids from Viburnum odoratissimum and Their Cytotoxic and HSP90 Inhibitory Activities.
    Zhu QF; Qi YY; Zhang ZJ; Fan M; Bi R; Su J; Wu XD; Shao LD; Zhao QS
    Chem Biodivers; 2018 May; 15(5):e1800049. PubMed ID: 29603623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.